Health Condition 1: M722- Plantar fascial fibromatosis
Conditions
Interventions
Intervention1: GROUP A: The subjects of this group will receive 25% Dextrose Prolotherapy with 2% 1ml of lignocaine.: â?¢The subjectâ??s will be placed in prone position with feet hanging over edge o
Sponsors
KGMU
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age 18-60 Years. 2.Idiopathic plantar fasciitis 3.Patient with clinically confirmed diagnosis of the plantar fasciitis refractory to conservative treatment of 2 weeks. 4.Subject willing to participate in the study
Exclusion criteria
Exclusion criteria: 1.Patient refusal to take part in study 2.Acute trauma of ankle and foot 3.Fracture or stress fracture of calcaneum 4.Acute infection (cellulitis, local abscess, septic arthritis) 5.Open wound over heel •Osteomyelitis of calcaneum •Entrapment neuropathy •Previous surgery of plantar fascia •The patient will excluded if they received local steroid injection within 1 month. •Non- steroidal anti-inflammatory drugs or acetylsalicylate with in 72 hours. •Patient with Hb- •Platelet count less than 150,000 per microliter of blood •Uncontrolled diabetes mellitus •Malignancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢Clinical parameter â?¢Assessment of pain-pain relief score (PRS) â?? baseline, 3rd and 6th weeks after injection â?¢Assessment of disability-foot functional index (FFI), foot and ankle outcome score (FAOS) â?? baseline 3rdand 6th weeks after injection Timepoint: at 0, 3rd week and 6th week | — |
Secondary
| Measure | Time frame |
|---|---|
| foot and ankle outcome scoreTimepoint: 0, 3rd , 6th weeks | — |
Countries
India
Contacts
Public ContactDr Sudhir R Mishra
King George medical university
Outcome results
None listed